Hi mbak Windy, Saya coba posting salah satu link artikel tentang Evaluasi dan Management treatment Rubella dari website _CDC_. Maaf artikelnya cukup panjang dan masih dalam versi bahasa Inggris.
Saya coba kutip bagian yang khusus tentang management treatment untuk wanita hamil yang terdeteksi Rubella (baik yang igG (+), igM (+), yang keduanya (+) atau (-)). Mungkin bisa jadi tambahan info untuk mbak. Seperti kata obgyn-nya mbak, memang Rubella termasuk salah satu virus dan tidak ada obatnya. Dari kutipan artikel ini sekilas saya baca, treatment-nya memang berkisar dengan test darah ulang juga monitor perkembangan fetus dan ibu. Best wishes untuk kehamilannya, ya mbak :) Sylvia - mum to Jovan, Rena & Aleta p.s. istilah dalam kutipan artikel di bawah: * CRI = Congenital Rubella Infection (Infeksi Rubella Bawaan Lahir) * CRS = Congenital Rubella Syndrom (Gejala Rubella Bawaan Lahir) ------------------------- http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5012a1.htm. Control and Prevention of Rubella: Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant Women, and Surveillance for Congenital Rubella Syndrome...... ...... (quoted) *Screening and Follow-Up of Pregnant Women Who Might Have Been Exposed to Rubella* Because the consequences of rubella infection during pregnancy are serious, every effort must be made to identify all women of childbearing age exposed to a person with confirmed, probable, or suspected rubella. Women found to be susceptible and not pregnant should be vaccinated as outlined previously (see All Women of Childbearing Age). Susceptible household contacts of pregnant women should also be vaccinated. All exposed pregnant women should be screened to determine if they a) were infected during pregnancy, b) are susceptible, or c) were immune before pregnancy. Because of the seriousness of CRI, immunity must be documented by a verified, dated record of a positive serologic test. Pregnant women without documented immunity should be tested for the presence of rubella IgG and IgM antibodies as outlined in this section. Identifying susceptible pregnant women is critical, so they can be isolated from further exposure, monitored for infection, and vaccinated postpartum. Pregnant women with evidence of infection during pregnancy should be evaluated to verify rubella infection and determine gestational age at time of infection, if possible, to assess the possibility of risk to the fetus. Immunoglobulin (IG) does not prevent rubella or mumps infection after exposure and is not recommended for that purpose (*18<http://www.cdc.gov/mmwr/preview/mmwrhtml/00053391.htm> *). Administration of IG after exposure to rubella will not prevent infection or viremia, but might modify or suppress symptoms and create an unwarranted sense of security. Therefore, IG is not recommended for routine postexposure prophylaxis of rubella in early pregnancy or any other circumstance. Infants with congenital rubella have been born to women who received IG shortly after exposure. Administration of IG should be considered only if a pregnant woman who has been exposed to rubella will not consider termination of pregnancy under any circumstances. In such cases, intramuscular administration of 20 mL of IG within 72 hours of rubella exposure might reduce --- but will not eliminate --- the risk for rubella. During an outbreak, the following steps should be taken to evaluate and follow up with pregnant women who had contact with a person with confirmed, probable, or suspected rubella: - Use documented serologic test results to verify immunity. If unavailable, conduct rubella IgG and IgM antibody testing regardless of symptom history. Pregnant women who are exposed to rubella and who do not have documented proof of immunity should be tested for rubella-specific IgM antibodies to identify recent infection. Because 20%--50% of rubella cases are asymptomatic, this testing policy is crucial to assess the possibility of risk to the fetus. Another way to identify recent infection is to detect a significant rise in paired IgG serum. A single positive IgG test indicates rubella immunity, but does not give information regarding the timing of the infection. However, a significant rise in IgG antibody (determined by testing paired sera) or positive IgM antibody test indicates recent infection. - Recommend restricting activities to avoid exposure while waiting for serologic test results. During this time, pregnant women should be excluded from activities (e.g., work or school) that present the possibility of exposure to persons with confirmed or suspected cases of rubella. Pregnant women found to be susceptible to rubella should avoid these settings for 6 weeks (two incubation periods) after the onset of symptoms of rubella in the last patient for whom rubella cannot be ruled out. - Evaluate exposed pregnant women with positive IgG titers and negative IgM to determine if they acquired immunity before pregnancy or infection during pregnancy. Women without previously documented immunity who were exposed during pregnancy and >6 weeks before IgM testing could test negative for IgM antibodies, which are normally not detectable >6 weeks after infection. Thus, a negative rubella IgM antibody assay does not rule out infection during pregnancy. The dates of the pregnancy, possible exposures, test(s), and history of rash illness should be considered in assessing the possibility of risk to the fetus. - Evaluate pregnant women with confirmed rubella to assess risk to the fetus. Rubella infection during the first 3 months of pregnancy is associated with the greatest risk for CRI, and up to 90% of infants born to mothers infected during the first 11 weeks of gestation will develop CRS. Infection late in the first half of pregnancy is more likely to result in hearing impairment and less likely to be associated with other defects. Although not likely to result in CRS, rubella infection late in pregnancy can result in congenital rubella infection only. - Pregnant women with negative IgG and negative IgM on first testing should be retested in 10--14 days; the first specimen should be reanalyzed along with the second specimen. A significant rise in IgG or positive IgM indicates recent infection. If a susceptible pregnant woman continues to be directly exposed to rubella, repeat tests of paired sera in 10--14 days to determine if infection occurs, then every 3--4 weeks if exposure continues. Testing can be performed earlier if pregnancy outcome might be influenced. Evaluate the infant on delivery for signs of CRS, and vaccinate the mother postpartum. - Recommend restricting activities for susceptible women (i.e., those without detectable IgG and IgM antibodies), obtain follow-up serologic testing, and vaccinate after delivery. Susceptible pregnant women should be excluded from activities (e.g., work or school) that present the possibility of exposure to persons with confirmed or suspected cases of rubella. Pregnant women found to be susceptible should avoid these settings for 6 weeks (two incubation periods) after the onset of symptoms of rubella in the last patient for whom rubella cannot be ruled out. Household contacts or other ongoing contacts without documented rubella immunity should be vaccinated. - Evaluate asymptomatic, exposed pregnant women with documented history of previous rubella immunity. Rubella reinfection is rare but has been documented (*19--22*). Women with documentation of previous rubella immunity who are exposed to rubella during pregnancy should consult their physicians. After discussing the potential for reinfection, physicians might recommend acute- and convalescent-phase IgG antibody testing or an IgM antibody test to document whether reinfection has occurred. However, the potential for false-positive IgM tests exists, and the potential risks and benefits of testing should be considered. - Counsel pregnant women with documentation of previous immunity to seek medical attention promptly if rubella-like symptoms appear. Any pregnant woman with documented immunity and rubella-like symptoms should be immediately evaluated by a physician to diagnose the symptoms and ensure the health of the mother and fetus. --------------- 2008/11/13 Windy Agustina <[EMAIL PROTECTED]> > Sakitnya pas 3 bulan.. > Rubella Igm nya +3,sekian... > Hamil 4 bulan cek lagi... hasilnya +11,sekian. > > Waktu konsultasi dokter... > Bliau bilang, bahwa Rubella itu virus. Tidak ada obatnya. > Jadi hanya di beri suplemen penambah daya tahan tubuh _inboost force_ kl > ga salah. > Dan satu hal lagi yg paling penting... berdoa... > Gitu katanya... > > Ya.. krn pengetahuan saya minim... > Sy berusaha mencari tau ttg Rubella dan pengobatannya. > > > <deleted> >
